301 BINNEY STREET, CAMBRIDGE, MA
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED), UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
Merger Agreement with Korsana Biosciences Inc. Amended
Other Events
Merger Agreement Announcement Conference Call, Investor Presentation
Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Investor Presentation
Q1
Amended Annual Report
Q3
Q2
FY 2024
Prospectus Filed Pursuant to Rule 425
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-4/A
PRE 14A
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Schedule 13G - Ownership Report
Schedule 13D - Ownership Report
Correspondence
Submission Upload